BHSC — Bioharvest Sciences Share Price
0.000.00%
Last trade - 00:00- CA$137.76m
- CA$149.00m
- $12.67m
- 33
- 14
- 80
- 38
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 23.47 | ||
| Price to Tang. Book | 23.47 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 4.33 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -49.4% | ||
| Return on Equity | n/a | ||
| Operating Margin | -35% | ||
Financial Summary
| Year End 31st Dec | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $m | n/a | 0.4 | 2.1 | 5.5 | 12.67 | 22.82 | 37.59 | n/a |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
BioHarvest Sciences Inc. is a Canada-based biotechnology company. The Company offers Botanical Synthesis, its patented technology process to grow plant-based molecules, without the need to grow the underlying plant. The Company is leveraging its Botanical Synthesis technology to develop the next generation of science-based and clinically proven therapeutic solutions within two major business verticals: as a contract development and production organization (CDMO) on behalf of customers seeking complex molecules, and as a creator of proprietary nutraceutical health and wellness products, which includes dietary supplements. The Company operates through two segments: Nutraceuticals and Pharmaceuticals. The Company offers a polyphenol/antioxidant superfruit product called VINIA, which is a red grape powder that supplies the benefits of red wine consumption but without the sugar, calories and alcohol found in wine.
Directors
- Last Annual
- December 31st, 2023
- Last Interim
- September 30th, 2024
- Incorporated
- April 19th, 2013
- Public Since
- August 5th, 2015
- Sector
- Food & Tobacco
- Industry
- Consumer Defensives
- Exchange
- Canadian Securities Exchange
- Shares in Issue
- 17,327,716
- Address
- 1140 - 625 Howe Street, VANCOUVER, V6C 2T6
- Web
- https://bioharvest.com/about/
- Phone
- +1 6046221186
- Contact
- David Ryan
- Auditors
- BDO & Co.
Upcoming Events for BHSC
Bioharvest Sciences Inc Annual Shareholders Meeting
Q1 2025 Bioharvest Sciences Inc Earnings Release
Similar to BHSC
Adaptogenics Health
Canadian Securities Exchange
Affinor Growers
Canadian Securities Exchange
Aretto Wellness
Canadian Securities Exchange
AREV Life Sciences Global
Canadian Securities Exchange
Ayurcann Holdings
Canadian Securities Exchange
FAQ
What is the Bioharvest Sciences share price?
As of Today at 18:36 UTC, shares in Bioharvest Sciences are trading at CA$7.95. This share price information is delayed by 15 minutes.
How has the Bioharvest Sciences share price performed this year?
Shares in Bioharvest Sciences last closed at CA$7.95 and the price had moved by +0.95% over the past 365 days. In terms of relative price strength the Bioharvest Sciences share price has underperformed the Toronto Stock Exchange 300 Composite Index by -15.8% over the past year.
What are the analyst and broker recommendations for Bioharvest Sciences?
The overall consensus recommendation for Bioharvest Sciences is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreWhat is the Bioharvest Sciences dividend yield?
Bioharvest Sciences does not currently pay a dividend.
Does Bioharvest Sciences pay a dividend?
Bioharvest Sciences does not currently pay a dividend.
When does Bioharvest Sciences next pay dividends?
Bioharvest Sciences does not currently pay a dividend.
How do I buy Bioharvest Sciences shares?
To buy shares in Bioharvest Sciences you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Bioharvest Sciences?
As of the previous close price of CA$7.95, shares in Bioharvest Sciences had a market capitalisation of CA$137.76m.
Where are Bioharvest Sciences shares listed?
Here are the trading details for Bioharvest Sciences:
- Country of listing: Canada
- Exchange: CNX
- Ticker Symbol: BHSC
What kind of share is Bioharvest Sciences?
Based on an overall assessment of its quality, value and momentum Bioharvest Sciences is currently classified as a Momentum Trap. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Bioharvest Sciences share price forecast for 2025?
The analyst consensus target price for shares in Bioharvest Sciences is CA$13.00. That is 63.52% above the last closing price of CA$7.95.
Analysts covering Bioharvest Sciences currently have a consensus Earnings Per Share (EPS) forecast of -$0.67 for the next financial year.
Find out moreWhat is the trend in the Bioharvest Sciences share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Bioharvest Sciences. Over the past six months, its share price has underperformed the Toronto Stock Exchange 300 Composite Index by -6.95%.
As of the last closing price of CA$7.95, shares in Bioharvest Sciences were trading -3.63% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Bioharvest Sciences PE Ratio?
The Bioharvest Sciences PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at CA$7.95.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Bioharvest Sciences?
We do not have data on Bioharvest Sciences' directors